financetom
Business
financetom
/
Business
/
Canadian Banks' U.S. Regulatory Filings Show "Weak Margins And Tepid Loan Growth"
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Banks' U.S. Regulatory Filings Show "Weak Margins And Tepid Loan Growth"
May 2, 2024 11:51 AM

02:35 PM EDT, 05/02/2024 (MT Newswires) -- Quarterly financial filings with the Fed (Call Reports) by Canadian banks with U.S. subsidiaries have just become available.

National Bank highlights the following takeaways:

BMO, CIBC and TD reported a similar decline in NIM (down 4-5 bps Q/Q). RBC recorded the most significant decline in NIM (down 11 bps Q/Q), with interest income falling 3% Q/Q and deposit costs increasing 2% Q/Q.

TD and CIBC saw sequential loan growth of 1% Q/Q and 2% Q/Q (mainly driven by its commercial loan portfolios), while loan growth was down 1% Q/Q for BMO and RBC. TD's 1% growth was led by commercial (+2% Q/Q), which offset a seasonal decline in card loans (down 6% Q/Q).

TD reported a US$450 million regulatory provision. The FDIC has also assessed an additional charge related to last year's bank crisis, estimated at roughly 15% of last quarter's figure (~mid-single-digit impact on NIX). Banks are expected to treat these items as "one-time" expenses.

CIBC's results included the largest sequential change in provisioning rate, at 27 bps Q/Q. Analyst Gabriel Dechaine attributes this performance largely to CECL volatility. In terms of non-accrual loans, BMO and TD reported a ~20% increase in this line item, while CIBC saw a 36% increase due to a doubling in C&I non-accrual loans.

Excluding the AOCI "opt-out", all U.S. operations of Canadian banks have CET 1 and leverage ratios solidly above current regulatory minimums of ~7-8% and ~4%, respectively. Additionally, all banks saw a significant Q/Q improvement in pro forma CET 1 ratios and were up on average ~40 bps Q/Q led by TD (up 80 bps) and RBC (up 60 bps).

Price: 123.00, Change: -0.34, Percent Change: -0.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Plumas Bancorp beats Q3 EPS estimates despite income drop
Plumas Bancorp beats Q3 EPS estimates despite income drop
Oct 15, 2025
Overview * Plumas Bancorp ( PLBC ) beats analysts' expectations for Q3 EPS despite decline in net income * Company's Q3 results were influenced by Cornerstone acquisition, which increased assets and deposits * Net interest income rose by $6.3 mln in Q3 2025 Outlook * Company expects cost of funds to decrease slightly following recent changes and Fed rate reduction...
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Largo (LGO.TO and NASDAQ: LGO) was at last look down more than 50% and at 52 week lows levels as its entered Wednesday into securities purchase agreements with institutional and accredited investors for the purchase and sale of 14,262,309 common shares of the company at a purchase price of US$1.22 per common share...
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Scynexis ( SCYX ) said Wednesday it will receive a $22 million payment from GSK's (GSK) GlaxoSmithKline Intellectual Property (No. 3) Limited, resolving the disagreement related to the restart of the phase 3 Mario study on invasive candidiasis. As per resolution terms, Scynexis ( SCYX ) will terminate the Mario study and receive...
Prologis tops quarterly estimates on strong warehouse leasing
Prologis tops quarterly estimates on strong warehouse leasing
Oct 15, 2025
Oct 15 (Reuters) - Warehouse-focused real estate investment trust Prologis ( PLD ) beat Wall Street estimates for third-quarter revenue and funds from operations on Wednesday, helped by robust demand for its storage facilities. The San Francisco, California-based company also raised its 2025 core FFO forecast to a range of $5.78 per share to $5.81 per share, from $5.75 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved